...
首页> 外文期刊>癌と化学療法 >A case of gastric cancer with abdominal para-aortic lymph node metastases responding to TS-1 + CDDP neoadjuvant chemotherapy
【24h】

A case of gastric cancer with abdominal para-aortic lymph node metastases responding to TS-1 + CDDP neoadjuvant chemotherapy

机译:胃癌患有胃癌患者的胃癌,响应TS-1 + CDDP Neoadjuvant化疗

获取原文
获取原文并翻译 | 示例
           

摘要

The patient was a 54-year-old woman with extremely advanced gastric cancer of type 3. A CT scan of the abdomen showed enlargement of many huge abdominal para-aortic lymph nodes. Combined chemotherapy of TS-1 and CDDP was planned in order to reduce the tumor. TS-1 (100 mg/body/day) was administered for 21 days followed by 14 days rest as one course. CDDP (96 mg/body) was administered 8 days after the start of TS-1. After 2 courses of treatment, a CT scan showed complete disappearance of lymph node metastasis, and no high grade toxicities. Therefore, one month after the completion of the chemotherapy, total gastrectomy and D2 lymph node dissection were performed. The histological effect was judged to be grade 1a-1b. There were no viable cancer cells in any lymph nodes. One year after surgery, the patient is still alive without recurrence. Neoadjuvant chemotherapy with TS-1 and CDDP is so effective that can it be adapted for advanced gastric cancer with para-aortic lymph node enlargement for downstaging.
机译:患者是一名54岁的女性,具有型胃癌的极高胃癌3.腹部的CT扫描显示出许多巨大的腹部对比淋巴结的扩大。计划组合的TS-1和CDDP化疗以减少肿瘤。施用TS-1(100mg /体/天)21天,然后休息14天。在TS-1开始后8天施用CDDP(96mg /体)。经过2种治疗过程,CT扫描显示淋巴结转移的完全消失,没有高级毒性。因此,在完成化疗完成后一个月,进行总胃切除术和D2淋巴结解剖。判断组织学效应为1A-1B级。任何淋巴结中没有可行的癌细胞。手术后一年,患者仍然活着,没有复发。 Neoadjuvant化疗与TS-1和CDDP是如此有效,可以适用于晚期胃癌与次瓣增大的预期淋巴结扩大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号